The BOKITO-2B Study: Tenofovir DF Bone and Kidney Toxicity.;Incidence and reversibility in HBV-monoinfected patients.

Phase 4

• Conditions: chronic hepatitis B; viral liver infection with hepatitis B virus; 10019654; 10047438

• Registration Number: NL-OMON35281
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 180

Inclusion Criteria

all adult, cHBV-infected patients on tenofovir or entecavir or without treatment are eligable

Exclusion Criteria

HIV-infection

Study & Design

• Study Type: Interventional
• Study Design: Not specified